Panel Discussion: What are the New Technologies to Enhance Our Understanding of Targeted Therapies?

Time: 3:10 pm
day: Day Two


• From target discovery to molecule developability – how can preclinical scientists work with biologists to assess the candidates’ effectiveness and mitigating downstream risks?
• From target validation to potency to safety – what are the new tools and bioinformatics we can leverage to help build a predictive model?